Cargando…
Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis
Autores principales: | Carcao, Manuel, Shapiro, Amy, Hwang, Nina, Pipe, Steven, Ahuja, Sanjay, Lieuw, Ken, Staber, Janice M., Belletrutti, Mark, Sun, Haowei Linda, Ding, Hilda, Wang, Michael, Price, Victoria, Steele, MacGregor, Tsao, Elisa, Feng, Jing, Al‐Khateeb, Zahra, Dumont, Jennifer, Jain, Nisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243250/ https://www.ncbi.nlm.nih.gov/pubmed/33210397 http://dx.doi.org/10.1111/hae.14192 |
Ejemplares similares
-
Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study
por: Malec, Lynn, et al.
Publicado: (2023) -
The changing face of immune tolerance induction in haemophilia A with the advent of emicizumab
por: Carcao, Manuel, et al.
Publicado: (2019) -
Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol
por: Camelo, Ricardo Mesquita, et al.
Publicado: (2021) -
Recombinant factor VIII Fc for the treatment of haemophilia A
por: Hermans, Cedric, et al.
Publicado: (2021) -
Pathogenic immune response to therapeutic factor VIII: exacerbated response or failed induction of tolerance?
por: Varthaman, Aditi, et al.
Publicado: (2019)